Richard J. Rodgers - Oct 29, 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Oct 29, 2025
Transactions value $
$0
Form type
4
Date filed
10/30/2025, 04:30 PM
Previous filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rodgers Richard J Director C/O NOVAVAX, INC., 700 QUINCE ORCHARD ROAD, GAITHERSBURG /s/ Mark J. Casey, Attorney-in-Fact 2025-10-30 0001313397

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise +3.8K +15.39% 28.5K Oct 29, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise $0 -3.8K -100% $0.00 0 Oct 29, 2025 Restricted Stock Units 3.8K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the October 29, 2022 grant date, in each case subject to continued employment through such vesting date.